Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
The effect of cordycepin on renal damage by correcting hypothyroidism
Hongyan Li1, Lili Qiao1, Jinhui Ma1
1Department of Endocrinology, Affiliated Hospital of Hebei University, Baoding City, Hebei Province, China.
Abstract:
The paper investigated the effect of cordycepin on renal damage induced by hypothyroidism and studied the effect of thyroid function recovery on renal damage. The hypothyroid rat model was established by continuous intragastric administration of propylthiouracil (PTU). The general state, thyroid function, renal function, blood lipid, pathological changes and damage of kidney tissues of rats in each group. The expressions of MCP-1 and Desmin proteins, which is a marker of podocyte damage, in the kidney were all detected by immunohistochemistry. The result of thyroid function examination was consistent with the characteristics of hypothyroidism. The renal damage and lipid metabolism disorder appeared in the hypothyroidism rats along with the progression of the disease, with the blood lipid increased and the expression of MCP-1 increased. Using this model to study the pathogenesis of hypothyroidism renal damage is more clinically practical and the administration of Cordycepin can improve the symptoms. Cordycepin can improve thyroid function, and can significantly alleviate renal damage in rats. By correcting thyroid function, Cordycepin can reduce renal damage and blood lipid, reduce the expressions of MCP-1 and Desmin proteins, thus delaying the progress of renal damage and protecting the kidney.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of Diuretics

